[Published 05/19/2026]
๐ ๐๐๐ฐ ๐๐ซ๐ ๐จ๐ ๐๐จ๐ง๐๐๐ฅ๐๐ญ๐ ๐๐๐ ๐ ๐๐ญ๐๐ซ๐ญ๐ฌ.
At #AUA2026, Sonablate Corp. marked a defining milestone in the evolution of ๐๐-๐๐จ๐๐จ๐ญ๐ข๐-๐๐๐ ๐ โ advancing the future of focal therapy and modern prostate care through innovation, education, collaboration, and real-world clinical experience. ย
Built on more than 30 years of pioneering leadership in HIFU and decades of ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐จ๐ง ๐ฐ๐ข๐ญ๐ก ๐ฉ๐ก๐ฒ๐ฌ๐ข๐๐ข๐๐ง๐ฌ, ๐ซ๐๐ฌ๐๐๐ซ๐๐ก๐๐ซ๐ฌ, ๐๐ง๐ ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐จ๐ฎ๐ง๐ ๐ญ๐ก๐ ๐ฐ๐จ๐ซ๐ฅ๐, AUA 2026 represented the next chapter of ๐๐ซ๐๐๐ข๐ฌ๐ข๐จ๐ง ๐๐จ๐ฎ๐ง๐ ๐๐๐๐ข๐๐ข๐ง๐. ย
A future built on one unwavering principle: ๐๐๐ฏ๐๐ง๐๐ข๐ง๐ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ-๐๐จ๐๐ฎ๐ฌ๐๐ ๐๐๐ซ๐ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐จ๐ง๐ญ๐ซ๐จ๐ฅ, ๐ฉ๐ซ๐๐ฌ๐๐ซ๐ฏ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ฎ๐ง๐๐ญ๐ข๐จ๐ง, ๐ช๐ฎ๐๐ฅ๐ข๐ญ๐ฒ ๐จ๐ ๐ฅ๐ข๐๐, ๐๐ง๐ ๐ซ๐๐ฌ๐ฉ๐๐๐ญ ๐๐จ๐ซ ๐๐๐๐ก ๐ฉ๐๐ญ๐ข๐๐ง๐ญโ๐ฌ ๐ ๐จ๐๐ฅ๐ฌ ๐จ๐ ๐๐๐ซ๐.
This vision came to life through four connected advancements shaping the next era of prostate care: ย
๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง โข ๐๐๐๐๐ฌ๐ฌ โข ๐๐ฎ๐ญ๐๐จ๐ฆ๐๐ฌ โข ๐๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ
๐น ๐๐ซ๐๐๐ข๐ฌ๐ข๐จ๐ง ๐๐จ๐ฎ๐ง๐ ๐๐๐๐๐๐ฆ๐ฒ โ building a global ecosystem to accelerate physician expertise, collaboration & the future growth of Precision Sound Medicine. ย
๐น ๐๐๐๐๐ข๐ง๐ ๐๐ฌ๐๐ซ ๐๐ฑ๐ฉ๐๐ซ๐ข๐๐ง๐๐ & ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ฑ๐๐๐ฅ๐ฅ๐๐ง๐๐ through ๐๐๐, ๐๐๐, ๐๐จ๐ฅ๐ฎ๐ฌ ๐๐ฎ๐ข๐๐, and ๐๐จ๐ง๐๐๐ฅ๐๐ญ๐ ๐๐ ๐๐๐ ๐ ๐ญ๐๐๐ก๐ง๐ข๐ช๐ฎ๐๐ฌโ advancing workflow efficiency, precision, and procedural adaptability for modern HIFU practice. ย
๐น Expanding physician experience and clinical discussion around HIFU applications in prostate โ๐๐ง๐ ๐๐ซ๐จ๐๐๐๐ฎ๐ซ๐. ๐๐ฐ๐จ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ.โ ย
๐น ๐๐จ๐ง๐๐๐๐๐๐ฌ๐ฌ โ creating a new digital connection point for patients & physicians through education, resources, and modern HIFU care access. ย
๐น Sonablateโs ๐ง๐๐ฐ ๐ฅ๐๐๐๐๐ซ๐ฌ๐ก๐ข๐ฉ ๐๐จ๐๐ซ๐ & ๐ฆ๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐ญ๐๐๐ฆ โ guiding the companyโs next phase of global growth, strategic collaboration.
๐น ๐๐จ๐ง๐ ๐ ๐๐๐๐๐ ๐๐๐ ๐ข๐ฌ๐ญ๐ซ๐ฒ โ a first-of-its-kind multinational real-world evidence platform designed to help shape the future of HIFU through long-term global data and collaboration. ย
This milestone was powered by pioneering physicians, researchers, societies, patient advocates, passionate leaders, and dedicated Sonablate team members around the world. ย
๐ ๐ง๐๐ฐ ๐๐ซ๐ ๐ข๐ฌ ๐ง๐จ๐ญ ๐๐ฎ๐ข๐ฅ๐ญ ๐จ๐ฏ๐๐ซ๐ง๐ข๐ ๐ก๐ญ.
It is built through ๐๐๐๐๐๐๐ฌ ๐จ๐ ๐ฏ๐ข๐ฌ๐ข๐จ๐ง, ๐๐จ๐ฎ๐ซ๐๐ ๐ ๐ญ๐จ ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐, ๐๐จ๐ฆ๐ฆ๐ข๐ญ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ, ๐๐ง๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐จ๐ง. ย
๐๐ก๐๐ง๐ค ๐ฒ๐จ๐ฎ to everyone who continues to help shape the future of AI-Robotic-HIFU and Precision Sound Medicine. ย
๐๐ก๐ ๐ฆ๐จ๐ฆ๐๐ง๐ญ๐ฎ๐ฆ ๐๐จ๐ง๐ญ๐ข๐ง๐ฎ๐๐ฌ.
โ
โ
Sonablateยฎ HIFU is FDAโcleared in the United States for the ablation of prostate tissue and was the first focused ultrasound device to receive FDA clearance for this indication. Sonablateยฎ HIFU is also available in more than 50 countries worldwide. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
โ
ยฉ 2026 Sonablate Corp. All rights reserved. Sonablateยฎ is a registered trademark of Sonablate Corp. Information on this website is for educational purposes only and is not a substitute for professional medical advice. Product availability, indications, and regulatory clearances may vary by region.
